Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma

Background & Aims: Adjuvant therapies for hepatocellular carcinoma (HCC) such as interferon-alpha are effective only in a subset of patients. Previously we found that HCC patients with low level of miR-26 have survival benefits from interferon-alpha. The purpose of this study is to develop a sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Junfang, Yu, Lei, Yu, Zhipeng, Forgues, Marshonna, Uenishi, Takahiro, Kubo, Shoji, Wakasa, Kenichi, Zhou, Jian, Fan, Jia, Tang, Zhao-You, Fu, Shijun, Zhu, Hongguang, Jin, Jason Gang, Sun, Hui-Chuan, Wang, Xin Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619096/
https://www.ncbi.nlm.nih.gov/pubmed/23569435
http://dx.doi.org/10.7150/ijbs.6214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619096/
https://www.ncbi.nlm.nih.gov/pubmed/23569435
http://dx.doi.org/10.7150/ijbs.6214

Ejemplares similares